Global Female Infertility Market, Global Female Infertility Market Report, Global Female Infertility Market Trends, Global Female Infertility Market Size

Female Infertility Market Size Forecast: Revenue and CAGR by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Female Infertility Industry In 2025?

The female infertility market has shown consistent expansion over recent years. Projections indicate it will expand from $1.79 billion in 2024 to $1.86 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.2%. This historical growth can be linked to several factors, including the increasing tendency of women to postpone childbirth, evolving lifestyle habits, increased government support, a rising elderly population, and the growing adoption of assisted reproductive technology (ART) treatments.

The female infertility market size is anticipated to experience consistent expansion over the next few years. It is projected to increase to $2.18 billion by 2029, achieving a compound annual growth rate (CAGR) of 4.0%. This growth during the forecast period is primarily driven by heightened awareness of fertility concerns, an increase in polycystic ovary syndrome cases, a rise in uterine abnormalities, a growing incidence of genetic disorders, and increasing rates of obesity. Significant developments expected within this period involve progress in preimplantation genetic testing, general technological advancements, innovative diagnostic technologies, fertility preservation techniques, and the adoption of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20787&type=smp

Which Industry Drivers Are Expected To Accelerate The Female Infertility Market From 2025 To 2029?

The expanding occurrence of infertility is projected to fuel the growth of the female infertility market in the future. Infertility is defined as the inability to achieve pregnancy after 12 months of regular, unprotected sexual intercourse. The rise in infertility is driven by factors such as delayed childbearing, shifts in lifestyle, environmental toxins, increasing obesity, and higher stress levels. Female infertility treatment is necessary to address and manage underlying medical, hormonal, or structural issues that impair fertility, consequently enhancing the likelihood of conception and averting permanent infertility. For instance, in July 2024, according to the Human Fertilization and Embryology Authority, a UK-based non-departmental public body of the Department of Health and Social Care, licensed fertility clinics in the UK performed nearly 77,000 fresh and frozen embryo transfer IVF cycles for 52,500 patients in 2022. Over 90% of these patients underwent treatment with a partner, involving approximately 100,000 individuals. Therefore, the increasing prevalence of infertility acts as a key driver for the growth of the female infertility market.

What Are The Key Segments In The Female Infertility Market?

The female infertilitymarket covered in this report is segmented –

1) By Treatment: Clomiphene Citrate; Gonadotropins; Metformin; Letrozole; Bromocriptine

2) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

3) By End-User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Subsegments:

1) By Clomiphene Citrate: Oral Clomiphene Citrate; Injectable Clomiphene Citrate

2) By Gonadotropins: Recombinant Gonadotropins; Urinary Gonadotropins; Human Chorionic Gonadotropin (hCG)

3) By Metformin: Immediate-Release Metformin; Extended-Release Metformin

4) By Letrozole: Oral Letrozole Tablets; Injectable Letrozole

5) By Bromocriptine: Oral Bromocriptine Tablets; Intranasal Bromocriptine

What Are The Major Trends Driving The Growth Of The Female Infertility Market?

Leading companies in the female infertility market are concentrating on developing innovative products, such as non-invasive diagnostic tests, to gain a competitive advantage. These medical tests identify conditions or diseases without requiring surgery or body penetration. For example, in August 2024, Heranova Lifesciences, a US-based biotech company, initiated an early access program for HerResolve, a non-invasive diagnostic test targeting endometriosis. This condition affects approximately 200 million women worldwide, manifesting symptoms like infertility, pain, and bleeding. Many women face an average diagnostic delay of 7-10 years from symptom onset, largely due to varied symptom presentation and the invasive nature of the most reliable diagnostic method, exploratory laparoscopic surgery. HerResolve aims to significantly reduce this diagnostic timeline from years to months, thereby improving patient care and healthcare outcomes.

Who Are The Top Performing Companies In The Female Infertility Market In Recent Years?

Major companies operating in the female infertility market are Pfizer Inc., Roche Holding AG, Merck And Co. Inc, Bayer AG, Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Commonwealth Serum Laboratories Ltd, Organon Theramex, Juniper Reproductive Health Ltd., Sumitomo Pharma, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Co., Mankind Pharma, Kissei Pharmaceutical Co Ltd, ASKA Pharmaceutical Co. Ltd., Fuji Pharma Co. Ltd., ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Hernova Lifesciences Holdings Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Female Infertility Market?

Europe was the largest region in the female infertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Female Infertility Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20787&type=smp

Browse Through More Reports Similar to the Global Female Infertility Market 2025, By The Business Research Company

Female Fertility And Pregnancy Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Pregnancy Test Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pregnancy-test-kits-global-market-report

Assisted Reproductive Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795